Institutional Ownership
Royalty Pharma PLC
CUSIP G7709Q104SHS CLASS ARPRXQ1 2026
13D / 13G Filings
39
Schedule 13D/13G on record
Beneficial Filers
15
Distinct reporting persons
Largest Stake
19.7%
Max % of class reported
Institutional Holders
576
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
39 filings · latest Feb 20, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 20, 2026 | R &Amp; H Trust Co. (Guernsey) Limited | 13D/A | 5.7% | — | SEC |
| 2 | Feb 13, 2026 | Capital International Investors | 13G/A | 7.7% | 32.75M | SEC |
| 3 | Nov 13, 2025 | Capital International Investors | 13G/A | 6.6% | 28.51M | SEC |
| 4 | Nov 5, 2025 | Fmr LLC | 13G/A | 6.5% | 27.90M | SEC |
| 5 | Oct 30, 2025 | The Vanguard Group | 13G/A | 2.5% | 10.94M | SEC |
| 6 | Aug 14, 2025 | General Atlantic, L.P. | 13G/A | 3.2% | 14.24M | SEC |
| 7 | Aug 13, 2025 | Capital International Investors | 13G | 5.5% | 23.11M | SEC |
| 8 | Aug 5, 2025 | Morgan Stanley | 13G/A | 9.2% | 38.91M | SEC |
| 9 | May 23, 2025 | Legorreta G. Pablo | 13D | 19.7% | — | SEC |
| 10 | May 12, 2025 | Fmr LLC | 13G/A | 9.1% | 39.25M | SEC |
29 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Royalty Pharma PLC.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Morgan Stanley | 43.57M | $2.09B |
| 2 | Capital International Investors | 35.01M | $1.68B |
| 3 | Blackrock, Inc. | 25.91M | $1.24B |
| 4 | Fmr LLC | 25.15M | $1.21B |
| 5 | Baillie Gifford & Co | 16.16M | $774.99M |
| 6 | Swedbank Ab | 11.59M | $555.81M |
| 7 | State Street Corp | 10.99M | $527.18M |
| 8 | Capital World Investors | 8.04M | $385.52M |
| 9 | Geode Capital Management, LLC | 7.87M | $376.52M |
| 10 | Adage Capital Partners Gp, L.L.C. | 7.48M | $358.85M |